SHL Medical AG
SHL Medical AG
09/07/2026 | Press release | Distributed by Public on 09/06/2026 19:29
Large-volume delivery spotlight at PODD 2026
Visit SHL Medical at Booth #112-113 to explore our autoinjectors and manufacturing solutions at PODD in Boston.
SHL Medical will return to Partnership Opportunities in Drug Delivery (PODD®) this year on October 29-30 in Boston, USA.
Growing attention on large-volume delivery is driving new developments in autoinjectors, where formulation characteristics, device design, manufacturing requirements, patient experience, and sustainability increasingly need to be considered together. At this year's PODD, SHL Medical experts will join partners and industry peers to explore these topics from multiple perspectives.
Across a series of scientific sessions, we will share insights spanning applied research, modeling and experimental data, usability, liquid-liquid drug delivery, and the evolving shift from IV to SC administration, looking beyond the device itself at what it takes to make new possibilities in subcutaneous delivery practical.
Beyond device innovation, we will highlight some of the capabilities that support drug delivery at scale. Our growing US presence, including the facilities in North Charleston and Deerfield Beach, brings development and manufacturing closer to our pharma partners in the region, while our broader approach to sustainability across product development reflects how we are strengthening the infrastructure behind our devices. Earlier this year, we earned an Ecovadis Gold rating, recognizing the progress we continue to make across our sustainability practices and operations.
These themes will be reflected at our booth as well, including perspectives on automation and tooling from SHL Advantec, our advanced manufacturing equipment sub-group.
At Booth #112-113, attendees can also get a first look at the latest evolution of our cartridge-based autoinjector for large-volume self-injection, alongside Quanta, Molly, and Reunite.
Register today and join us at PODD to explore the technologies, research, and capabilities supporting the evolving needs of subcutaneous drug delivery.
Meet our speakers
Podium presentation
|
Topic |
Speakers |
Date and Time |
|
Pushing The Limits: Part II - Proving What's Possible |
Alex Lyness, PhD Head of Innovation Strategy and Applied Research, SHL Medical |
October 30 11:50 AM EDT |
Panel session
|
Topic |
Speakers |
Date and Time |
|
How is IV to SC Evolving? |
Courtney Nicholas Sutton Head of Portfolio Strategy, SHL Medical |
October 30 2:00 PM EDT |
Tech Talk
|
Topic |
Presenters |
Date and Time |
|
A Collaborative Approach to Linking Modeling and Experimental Data for High-Viscosity, Non-Newtonian Subcutaneous Delivery via an Autoinjector |
Thomas James Customer Solutions Manager, SHL Medical |
October 29 3:00 PM EDT |
|
Ludovic Gil, PhD Research and Development Manager, BD |
||
|
Audible Feedback for Long-Duration Autoinjectors: User Experience Considerations for Injections Beyond 15 Seconds |
Nenad Suknovic, PhD Senior Usability Engineer Research Lead, SHL Medical |
October 29 3:15 PM EDT |
|
Amy King, PhD Head of Insights and Strategy, Cambridge Design Partnership |
||
|
Unlocking a Standardized Ecosystem for Liquid-Liquid Drug Delivery Through Partnership |
Thomas James Customer Solutions Manager, SHL Medical |
October 29 5:30 PM EDT |
|
Jake Skare Product Manager, Stevanato Group |
Where : Sheraton Boston Hotel, Boston, USA | Booth #112-113
When : October 29-30
SHL Medical AG published this content on September 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 07, 2026 at 01:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]